GSK one-year nonexclusive licence to 23andMe de-identified genetic data, plus analysis services
$20 million upfront
USD upfront per one-year nonexclusive data licence (one contract), US
“Under an amendment to their collaboration agreement, 23andMe will receive a $20 million upfront payment for a one year, non-exclusive data license.”
- Kind of source
- The payer's or seller's own page
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- The licence also bundles services such as further analyses of 23andMe data not in the core data release, so the $20 million is not data alone.
- About
- Consumer DNA test
Used in
Kept as evidence; no figure on the platform is computed from it yet.